Skip to main content
Stefanie Sarantopoulos, MD, Oncology, Durham, NC

StefanieSarantopoulosMDPhD

Oncology Durham, NC

Hematologic Oncology

Associate professor

Dr. Sarantopoulos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sarantopoulos' full profile

Already have an account?

  • Office

    40 Duke Medicine Cir
    Durham, NC 27710
    Phone+1 919-684-8111
    Fax+1 919-620-4921

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2005
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1998 - 2002
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1998
  • Boston University School of Medicine
    Boston University School of MedicinePh.D., 1998
  • Mount Holyoke College
    Mount Holyoke CollegeB.A., Biochemistry, 1988

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2009 - 2025
  • MA State Medical License
    MA State Medical License 2001 - 2009
  • ABIMHematology

Awards, Honors, & Recognition

  • American Society for Clinical Investigation ASCI, 2017
  • UNC Excellence Award 2010
  • Amy Strelzer Manasevit Scholar 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Notch Signaling Mediated by Delta-like1/4 Ligands Controls the Pathogenesis of Chronic Graft-Versus-Host Disease in Mice  
    Ivan Maillard, Eric T Perkey, Maria A Pletneva, Stefanie Sarantopoulos, Bruce R Blazar, Vedran Radojcic, Blood
  • Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients with Pulmonary Involvement  
    Keith M Sullivan, Ankoor Shah, Daniel E Furst, Stefanie Sarantopoulos, Arthritis & Rheumatology
  • A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantation  
    Aria S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Plamer J, Chen GL, Jagasia M, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM..., Clin Cancer Res, 1/1/2015
  • Join now to see all

Abstracts/Posters

  • Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host Disease
    Stefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...
    Stefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell Transplantation
    Stefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • B cells in Chronic GVHD 
    1/18/2015
  • Burgeoning Roles of B Cells in Transplant 
    1/1/2013
  • B Cells and Transplantation 
    Tampa, FL - 1/1/2009

Other

  • Generation of recombinant polyclonal antibody libraries against tumor cells (thesis) 
    Sarantopoulos S, Boston University School of Medicine
    Boston, MA - 1/1/1996
  • Separation of monomers and dimmers of glyceraldehydes-3-phosphate dehydrogenase (thesis) 
    Sarantopoulos S, Mt. Holyoke College
    South Hadley, MA - 1/1/1988

Press Mentions

  • Axatilimab Shows Robust Activity in Chronic Graft-Versus-Host-Disease Trial
    Axatilimab Shows Robust Activity in Chronic Graft-Versus-Host-Disease TrialDecember 20th, 2023

Grant Support

  • Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHDNIH (NHLBI)2015–2020
  • The Notch2-BCR Axis: Targeting Drivers of B Cell Fate in Chronic GVHDThe Leukemia & Lymphoma Society2015–2018

Committees

  • Elected Board Member, Director of Laboratory Sciences for American Society of Bone Marrow Transplantation 2018 - Present
  • Invited member, NIH Consensus Criteria on Chronic Graft versus Host Disease, subcommittee on Biology and Biomarkers 2013 - Present
  • Invited member, Autoimmune Diseases and Cell Therapy Working for the CENTER FOR INTERNATIONAL BLOOD & MARROW TRANSPLANT RESEARCH (CIBMTR) Committee 2013 - Present

Professional Memberships

Other Languages

  • German